Alamar Biosciences

Alamar Biosciences is a life sciences company focused on precision proteomics for early disease detection. Their proprietary NULISA Platform and ARGO HT System offer high-sensitivity protein detection, enabling biomarker discovery and non-invasive disease testing. This technology surpasses existing methods in sensitivity and dynamic range.

Buy Funded Startups lists

Funding Round: Series C

Funding Amount: $128M

Date: 26-Feb-2024

Investors: Sands Capital

Markets: Biotechnology, Proteomics, Health Care, Medical, Diagnostic Equipment, Decision/Risk Analysis

HQ: Fremont, California, United States

Founded: 2018

Website: https://www.alamarbio.com/

LinkedIn: https://www.linkedin.com/company/alamar-biosciences-inc

Twitter: https://twitter.com/AlamarBio

Instagram: